{"title":"神经束蛋白-155免疫球蛋白引起的神经病变:临床特征和预后","authors":"Leana Doherty","doi":"10.1056/NEJM-JW.NA54230","DOIUrl":null,"url":null,"abstract":"Little is known about long-term outcomes in patients with neuropathy and neurofascin-155 immunoglobulin G4 (NF155-IgG4) antibodies, and even less about","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Neuropathy with Neurofascin-155 Immunoglobulins: Clinical Profile and Prognosis\",\"authors\":\"Leana Doherty\",\"doi\":\"10.1056/NEJM-JW.NA54230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Little is known about long-term outcomes in patients with neuropathy and neurofascin-155 immunoglobulin G4 (NF155-IgG4) antibodies, and even less about\",\"PeriodicalId\":19048,\"journal\":{\"name\":\"NEJM Journal Watch\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NEJM Journal Watch\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1056/NEJM-JW.NA54230\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NEJM Journal Watch","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1056/NEJM-JW.NA54230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Neuropathy with Neurofascin-155 Immunoglobulins: Clinical Profile and Prognosis
Little is known about long-term outcomes in patients with neuropathy and neurofascin-155 immunoglobulin G4 (NF155-IgG4) antibodies, and even less about
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
